11Feb 2023
Robotic retroperitoneal lymph node dissection: a systematic review of perioperative outcomes

Robotic retroperitoneal lymph node dissection: a systematic review of perioperative outcomes

Robotic retroperitoneal lymph node dissection(R‐RPLND) is a minimally invasive treatment option for testis cancer. This systematic review assessed the safety and feasibility of R‐RPLND and compared the perioperative outcomes of R‐RPLND with open RPLND (O‐RPLND). For primary R‐RPLND, the operative time ranged from 175‐540 minutes, and the major complication rate was 4.1%. For post‐chemotherapy R‐RPLND, the operative time ranged from 134‐550 min, and the major complication rate was 8.5%. The conversion rate to open surgery was 2.2% in primary R‐RPLND and 9.0% in post‐chemotherapy R‐RPLND. Compared with O‐RPLND, R‐RPLND was associated with a lower transfusion rate and complication rate. Based on the findings, R‐RPLND has acceptable perioperative outcomes in both the primary and post‐chemotherapy settings.

  • #urology

Like

Save

Share